Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Phase I Trial Assessing Lomecel-B Infusion in Individuals with Alzheimer’s Disease: Study Design and Rationale

Autor: Ramdas, Kevin, Hitchinson, Ben, McClain-Moss, Lisa, Yousefi, Keyvan, Diaz, Liliana, Baumel, Barry, Hare, Joshua, Oliva, Anthony

Publikováno v: Innovation in Aging

Alzheimer’s disease (AD) is an irreversible neurodegenerative disorder characterized by memory loss and persistent cognitive dysfunction which significantly compromises quality of life. Brain inflammation is a prominent feature of AD pathology. Lom

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ac2aee510a040f294529114a3e211bf
https://doi.org/10.1093/geroni/igab046.2453

Aborting a Migraine Attack: Naproxen Sodium v Ergotamine plus Caffeine.

Autor: Sargent, Joseph D., Baumel, Barry, Peters, Kenneth, Diamond, Seymour, Saper, Joel R., Eisner, Larry S., Solbach, Patricia

Publikováno v: Headache: The Journal of Head & Face Pain; May1988, Vol. 28 Issue 4, p263-266, 4p

Migraine.

Autor: Baumel, Barry

Publikováno v: Neurology; 1994 Supplement, Vol. 44, pS13-S17, 5p

Easing the burden of Alzheimer's disease: therapeutic options

Autor: Baumel, Barry

Publikováno v: European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies; October 1998, Vol. 5 Issue: Supplement 4 pS19-S29, 11p